Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-4,795
Closed -$996K 24
2025
Q2
$996K Sell
4,795
-142
-3% -$30.6K 0.29% 72
2025
Q1
$1.01M Sell
4,937
-9,086
-65% -$1.81M 0.23% 81
2024
Q4
$2.56M Sell
14,023
-332
-2% -$69.8K 0.59% 38
2024
Q3
$2.95M Sell
14,355
-545
-4% -$105K 0.69% 37
2024
Q2
$2.61M Sell
14,900
-92
-0.6% -$15.7K 0.65% 39
2024
Q1
$2.58M Sell
14,992
-460
-3% -$70.8K 0.68% 36
2023
Q4
$2.33M Sell
15,452
-4,208
-21% -$564K 0.69% 39
2023
Q3
$2.38M Buy
19,660
+184
+0.9% +$22.9K 1.06% 28
2023
Q2
$2.42M Sell
19,476
-504
-3% -$59.1K 1.04% 28
2023
Q1
$2.31M Sell
19,980
-2,572
-11% -$283K 1.17% 24
2022
Q4
$2.55M Sell
22,552
-212
-0.9% -$22.9K 1.43% 21
2022
Q3
$2.21M Buy
22,764
+544
+2% +$55.5K 1.49% 20
2022
Q2
$2.08M Sell
22,220
-2,372
-10% -$231K 1.18% 26
2022
Q1
$2.62M Buy
24,592
+904
+4% +$87.9K 1.26% 23
2021
Q4
$2.62M Sell
23,688
-976
-4% -$105K 1.17% 23
2021
Q3
$2.67M Buy
24,664
+724
+3% +$70.8K 1.27% 21
2021
Q2
$2.29M Sell
23,940
-1,264
-5% -$112K 1.2% 23
2021
Q1
$2.15M Buy
25,204
+10,760
+74% +$911K 1.25% 27
2020
Q4
$1.22M Buy
14,444
+412
+3% +$35.8K 0.72% 43
2020
Q3
$1.19M Buy
14,032
+1,808
+15% +$139K 0.74% 43
2020
Q2
$922K Buy
+12,224
New +$707K 0.63% 46

Other funds holding CTAS

DOHJ LLC's CTAS Position: Q3 2025 in Review

DOHJ LLC sold out of Cintas (CTAS) in Q3 2025, closing a stake of 4,795 shares — an estimated $996K sold.

DOHJ LLC first reported a position in CTAS in Q2 2020 and held it in 21 quarters. The position peaked at $2.95M in Q3 2024. 1,462 funds tracked by Wall St. Rank hold CTAS as of Q3 2025.

  • DOHJ LLC reported no remaining Cintas position as of Q3 2025 after selling out during the quarter.
  • DOHJ LLC sold 4,795 Cintas shares in Q3 2025, an estimated $996K.
  • DOHJ LLC first reported a position in Cintas in Q2 2020 and held it in 21 quarters.
  • DOHJ LLC's Cintas position peaked at $2.95M in Q3 2024.
  • 1,462 funds tracked by Wall St. Rank held Cintas as of Q3 2025.

Based on DOHJ LLC's 13F filing for Q3 2025.